232 related articles for article (PubMed ID: 7657277)
21. Evidence of a dynamic aldosterone-independent distal tubular control of renal sodium excretion in compensated liver cirrhosis.
Sansoè G; Silvano S; Rosina F; Smedile A; Rizzetto M
J Intern Med; 2005 Apr; 257(4):358-66. PubMed ID: 15788006
[TBL] [Abstract][Full Text] [Related]
22. [Increase in absolute atmospheric pressure in hyperbaric chamber in cirrhosis with ascites: lack of natriuretic response and increase of atrial natriuretic peptide].
Gambini G; Fioroni E; Guerra M; Moscatelli A; Valori C
Minerva Med; 1994 Mar; 85(3):77-81. PubMed ID: 8196847
[TBL] [Abstract][Full Text] [Related]
23. Atrial natriuretic peptide: renal effects in cirrhosis of the liver.
Levy M
Semin Nephrol; 1997 Nov; 17(6):520-9. PubMed ID: 9353863
[TBL] [Abstract][Full Text] [Related]
24. Effects of nifedipine, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate hydrochloride and atrial natriuretic peptide on endothelin-induced antinatriuresis in dogs.
Takagi H; Takahara A; Tomura Y; Yamagata T; Hisa H; Satoh S
J Pharmacol Exp Ther; 1993 Oct; 267(1):456-61. PubMed ID: 8229776
[TBL] [Abstract][Full Text] [Related]
25. Natriuretic action of ANP is blunted by ACE inhibition in humans.
Wambach G; Schittenhelm U; Stimpel M; Bönner G; Kaufmann W
J Cardiovasc Pharmacol; 1989 May; 13(5):748-53. PubMed ID: 2472523
[TBL] [Abstract][Full Text] [Related]
26. Human atrial natriuretic peptide (ANP) for the treatment of patients with liver cirrhosis and ascites.
Brabant G; Jüppner H; Kirschner M; Böker K; Schmidt FW; Hesch RD
Klin Wochenschr; 1986; 64 Suppl 6():108-11. PubMed ID: 2948056
[TBL] [Abstract][Full Text] [Related]
27. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising.
Burghardt W; Müller R; Diehl KL; Wernze H
Z Kardiol; 1988; 77 Suppl 2():104-10. PubMed ID: 2970163
[TBL] [Abstract][Full Text] [Related]
28. Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention.
Carstens J; Grønbaek H; Larsen HK; Pedersen EB; Vilstrup H
BMC Gastroenterol; 2007 Jan; 7():1. PubMed ID: 17257428
[TBL] [Abstract][Full Text] [Related]
29. Interaction of atrial natriuretic peptide and amiloride on renal hemodynamics through renal kallikrein and kinins in anesthetized rabbits.
Seino M; Abe K; Nushiro N; Omata K; Yoshinaga K
J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S39-42. PubMed ID: 2473347
[TBL] [Abstract][Full Text] [Related]
30. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N
Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
[TBL] [Abstract][Full Text] [Related]
31. [Regulation of natriuresis in diabetic nephropathy].
Późniak J
Ann Acad Med Stetin; 2000; 46():241-52. PubMed ID: 11712308
[TBL] [Abstract][Full Text] [Related]
32. Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention.
La Villa G; Riccardi D; Lazzeri C; Casini Raggi V; Dello Sbarba A; Tosti Guerra C; Fronzaroli C; Foschi M; Laffi G; Gentilini P
Hepatology; 1995 Dec; 22(6):1745-50. PubMed ID: 7489983
[TBL] [Abstract][Full Text] [Related]
33. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
[TBL] [Abstract][Full Text] [Related]
34. Atrial natriuretic peptide in hepatic cirrhosis: relation to stage of disease, sympathoadrenal system and renin-aldosterone axis.
Burghardt W; Wernze H; Diehl KL
Klin Wochenschr; 1986; 64 Suppl 6():103-7. PubMed ID: 2948055
[TBL] [Abstract][Full Text] [Related]
35. Dose-response study of atrial natriuretic peptide bolus injection in healthy man.
Eiskjaer H; Pedersen EB
Eur J Clin Invest; 1993 Jan; 23(1):37-45. PubMed ID: 8383057
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
[TBL] [Abstract][Full Text] [Related]
37. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.
Eiskjaer H; Nielsen CB; Pedersen EB
J Intern Med; 1994 Dec; 236(6):665-74. PubMed ID: 7989902
[TBL] [Abstract][Full Text] [Related]
38. Effect of atrial natriuretic peptide on arterial pressure and renal function in cirrhotic rats with ascites.
López C; Jiménez W; Arroyo V; Gaya J; Rivera F; Rodés J
Rev Esp Fisiol; 1988 Sep; 44(3):265-72. PubMed ID: 2976517
[TBL] [Abstract][Full Text] [Related]
39. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
Olsen NV
Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
[TBL] [Abstract][Full Text] [Related]
40. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
